Abstract:MicroRNAs play a crucial role in regulating cartilage extracellular matrix (ECM) metabolism and are being explored as potential therapeutic targets for osteoarthritis (OA). The present study indicated that microRNA-224-5p (miR-224-5p) could balance the homeostasis of OA via regulating cartilage degradation and synovium inflammatory simultaneously. Multifunctional polyamidoamine dendrimer with amino acids used as efficient vector to deliver miR-224-5p. The vector could condense miR-224-5p into transfected nanoparticles, which showed higher cellular uptake and transfection efficiency compared to lipofectamine 3000, and also protected miR-224-5p from RNase degradation. After treatment with the nanoparticles, the chondrocytes showed an increase in autophagy rate and ECM anabolic components, as evidenced by the upregulation of autophagy-related proteins and OA-related anabolic mediators. This led to a corresponding inhibition of cell apoptosis and ECM catabolic proteases, ultimately resulting in the alleviation of ECM degradation. In addition, miR-224-5p also inhibited human umbilical vein endothelial cells angiogenesis and fibroblast-like synoviocytes inflammatory hyperplasia. Integrating the above synergistic effects of miR-224-5p in regulating homeostasis, intra-articular injection of nanoparticles performed outstanding therapeutic effect by reducing articular space width narrowing, osteophyte formation, subchondral bone sclerosis and inhibiting synovial hypertrophy and proliferation in the established mouse OA model. The present study provides a new therapy target and an efficient intra-articular delivery method for improving OA therapy. Statement of Significance Osteoarthritis (OA) is the most prevalent joint disease worldwide. Gene therapy, which involves delivering microRNAs, has the potential to treat OA. In this study, we demonstrated that miR-224-5p can simultaneously regulate cartilage degradation and synovium inflammation, thereby restoring homeostasis in OA gene therapy. Moreover, compared to traditional transfection reagents such as lipofectamine 3000, G5-AHP showed better efficacy in both microRNA transfection and protection against degradation due to its specific surface structure. In summary, G5-AHP/miR-224-5p was developed to meet the clinical needs of OA patients and the high requirement of gene transfection efficiency, providing a promising paradigm for the future application and development of gene therapy.

Effect of microRNA on metabolism of cartilage

The mechanism advance of MicroRNA in cartilage injury and degeneration

Lncrnas: Function and Mechanism in Cartilage Development, Degeneration, and Regeneration

Effect of the Interaction Between MiR-200b-3p and DNMT3A on Cartilage Cells of Osteoarthritis Patients.

Roles of microRNAs in prenatal chondrogenesis, postnatal chondrogenesis and cartilage-related diseases.

MicroRNAs Play a Role in Chondrogenesis and Osteoarthritis (Review)

MicroRNA-15a/β1,4-GalT-I Axis Contributes to Cartilage Degeneration Via NF-κB Signaling in Osteoarthritis

MicroRNA and osteoarthritis: a review of the literature

[Effects of cartilage progenitor cells and microRNA-140 on repair of osteoarthritic cartilage injury].

MicroRNAs associated with osteoarthritis differently expressed in bone matrix gelatin (BMG) rat model.

Recent progress on the role of miR-140 in cartilage matrix remodelling and its implications for osteoarthritis treatment

microRNA-544a as a new modulator of the Wnt-signalling network in the articular cartilage and osteoarthritis

MicroRNA-10a-3p Improves Cartilage Degeneration by Regulating CH25H-CYP7B1-RORα Mediated Cholesterol Metabolism in Knee Osteoarthritis Rats

Role of the Cirs-7/Mir-7 Axis in the Regulation of Proliferation, Apoptosis and Inflammation of Chondrocytes Induced by IL-1β.

Integrated Bioinformatics Analysis of the Osteoarthritis‑associated Microrna Expression Signature.

MicroRNA-210-3p Promotes Chondrogenic Differentiation and Inhibits Adipogenic Differentiation Correlated with HIF-3α Signalling in Bone Marrow Mesenchymal Stem Cells.

MicroRNA-486 Promotes a More Catabolic Phenotype in Chondrocyte-Like Cells by Targeting SIRT6 POSSIBLE INVOLVEMENT IN CARTILAGE DEGRADATION IN OSTEOARTHRITIS

MicroRNA-218-5p As a Potential Target for the Treatment of Human Osteoarthritis.

The Role of Mitochondrial Metabolism, AMPK-SIRT Mediated Pathway, LncRNA and MicroRNA in Osteoarthritis

Mir-146A Facilitates Osteoarthritis by Regulating Cartilage Homeostasis Via Targeting Camk2d and Ppp3r2.

MicroRNA-224-5p nanoparticles balance homeostasis via inhibiting cartilage degeneration and synovial inflammation for synergistic alleviation of osteoarthritis